Balchem Corporation (BCPC) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 1 252 sessions, November 10, 2025 to November 10, 2026
- Largest daily move
- -6.8% close of April 30, 2026
- 1-year change
- +11.8% closing prices, November 10, 2025 to November 10, 2026
- 1-month change
- +3.4% closing prices, October 9, 2026 to November 10, 2026
Company Description
Balchem Corporation (NASDAQ: BCPC) is a global specialty ingredient manufacturer focused on health and nutrition markets. According to the company’s public disclosures and recent news releases, Balchem develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, supplying customers across a range of industries worldwide.
Balchem reports three primary business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. This segment structure is consistently described in the company’s press releases and SEC filings and forms the core of its business model.
Human Nutrition & Health
The Human Nutrition & Health segment is described by Balchem as delivering customized food and beverage ingredient systems and key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. In earlier descriptions and current news, this segment is also associated with human-grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. Through this segment, Balchem participates in markets where ingredient systems and nutrients are incorporated into finished food, beverage, dietary supplement and pharmaceutical products.
Animal Nutrition & Health
The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Company materials also associate this segment with nutritional products derived from Balchem’s microencapsulation and chelation technologies, in addition to the essential nutrient choline chloride. Balchem is identified as a producer of choline chloride in the European Union and has publicly commented on EU anti-dumping measures on choline chloride imports, underscoring the importance of this nutrient to its animal nutrition activities and to the broader food and feed supply chain.
Specialty Products
Through its Specialty Products segment, Balchem provides specialty-packaged chemicals and performance gases for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. Company communications describe this segment as including the re-packaging and distribution of performance gases and chemicals, as well as plant nutrition offerings based on chelated minerals.
Industry and Operations
Balchem is classified in the Other Animal Food Manufacturing industry within the broader Manufacturing sector. Its disclosures emphasize specialty performance ingredients, nutrients and delivery systems rather than commodity products. The company highlights microencapsulation and chelation technologies as important to its human and animal nutrition offerings, and it reports segment-level financial results for Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products in its periodic financial releases and related Form 8-K filings.
Balchem’s public statements also reference its role in supporting food and feed supply chains, particularly through choline chloride production in the EU, and its participation in health, nutrition and industrial markets through its specialty ingredients and packaged chemicals. The company’s shares trade on NASDAQ under the ticker symbol BCPC, and it files periodic and current reports with the U.S. Securities and Exchange Commission, including earnings-related Form 8-K filings.
Business Model Overview
Based on the company’s segment descriptions, Balchem’s business model centers on developing and manufacturing specialty ingredients and chemical products, then marketing them into human nutrition, animal nutrition, healthcare, agricultural and other industrial applications. Revenue is organized and reported by segment, reflecting the different end markets served: human nutrition and health applications, animal nutrition and health markets, and specialty-packaged chemicals and performance gases, along with chelated minerals for micronutrient agriculture.
Regulatory and Public Company Profile
Balchem Corporation is incorporated in Maryland and is registered with the SEC under Commission File Number 1-13648. It has reported financial results for recent quarters via Form 8-K filings that reference accompanying press releases detailing segment net sales, earnings from operations and other financial measures. The company also holds an annual meeting of shareholders, as disclosed in a Form 8-K reporting voting results on director elections, auditor ratification and advisory approval of executive compensation.
According to multiple news releases, Balchem describes itself as a global specialty ingredient manufacturer for health and nutrition markets and as a developer, manufacturer and marketer of specialty ingredients and products for a range of industries worldwide. Its combination of human nutrition, animal nutrition and specialty chemical activities positions the company within the broader manufacturing and specialty ingredients landscape.
Stock Performance
Balchem Corporation (BCPC) closed at $173.54 on November 10, 2026. Over the past 12 months, the price has gained 11.8%.
BCPC Metrics & Rankings
Price returns through November 10, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Balchem Corporation has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include earnings, conferences. View all BCPC news →
SEC Filings
Balchem Corporation has filed 10 recent SEC filings, including 5 Form 8-K, 3 Form 10-Q, 1 Form 3, 1 Form SCHEDULE 13G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BCPC SEC filings →
Financial Highlights
Balchem Corporation generated $1.0B in revenue in FY2025, retaining a 35.7% gross margin, operating income reached $209.3M (20.2% operating margin), and net income was $154.8M, reflecting a 14.9% net profit margin. Diluted earnings per share stood at $4.75. The company generated $216.6M in operating cash flow. The current ratio was 2.07, measuring current assets divided by current liabilities.
Upcoming Events
Baird Conference Presentation
Revolving Facility Maturity
Balchem Corporation has 2 upcoming scheduled events. The next event, "Baird Conference Presentation", is scheduled for November 11, 2026 (tomorrow). 1 of them is a financing or capital event, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the BCPC stock price.
Short Interest History
Short interest in Balchem Corporation (BCPC) currently stands at 517.0 thousand shares, up 4.9% from the previous reporting period, representing 1.6% of the float. Since November 2025, short interest has increased by 12.6%.
Days to Cover History
Days to cover for Balchem Corporation (BCPC) currently stands at 2.0 days, down 5.8% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has decreased by 36.4%. Across the settlements charted above, it has ranged from 1.4 to 3.5 days.
BCPC Company Profile & Sector Positioning
Balchem Corporation (BCPC) operates in the Specialty Chemicals industry within the broader Basic Materials sector and is listed on the NASDAQ. Among dividend-paying stocks, BCPC ranks #1,902 by dividend yield.
Investors comparing BCPC often look at related companies in the same sector, including Sensient Technology Corporation (SXT), NewMarket Corporation (NEU), Perimeter Group Inc. (PRM), Element Solutions Inc. (ESI), and Eastman Chemical Company (EMN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BCPC's relative position within its industry.